Clinical trial
EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion
NCT00647192 is registered in ClinicalTrials.gov with University Hospital, Saarland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion
- Lead sponsor
- University Hospital, Saarland
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2008
- Completion date
- February 29, 2012
- Enrollment
- 38 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.